Page results
-
The Royal National ENT and Eastman Dental Hospitals is one of the UK's largest centres for ENT surgery, it offers a wide range of services from a multidisciplinary team. The ENT out-patient department provides both routine and specialist clinics including some nurse-led clinics. Referral to this service is via your GP.
-
Laryngology is part of ENT, it is a surgical specialty for adults and children with throat complaints.
-
This is information for women about medical management after an ultrasound diagnosis of a miscarriage.
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
-
We run two separate Urogynaecology services at UCH: the Urogynaecology and Pelvic Floor Unit and the Female Pelvic Medicine and Reconstructive Surgery Unit.
-
This is a unique service screening women at risk of ovarian cancer due to a strong family history.
-
University College Hospital is one of only eight centres in London that has a Hyper-acute Stroke Unit or a HASU as they are known.
-
We are an established service that has worked closely with thousands of people living with MS across North London and Hertfordshire.
-
The Fetal Medicine Unit (FMU) is led by a team of highly skilled specialist doctors that offer diagnosis and treatment of complications which may arise in unborn babies.
File results
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0542 - Pulmonary rehabilitation (PR)
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0522 - Urology cancer pathway
-
FOI/2023/0561 - Birthrate Plus